Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS)
CNY 4.77
(0.0%)
CNY 4.77
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.33 Billion CNY | 18.18% |
| 2022 | 1.12 Billion CNY | 22.14% |
| 2021 | 923.41 Million CNY | -3.96% |
| 2020 | 961.45 Million CNY | -24.51% |
| 2019 | 1.27 Billion CNY | 9.51% |
| 2018 | 1.16 Billion CNY | 27.58% |
| 2017 | 911.66 Million CNY | 37.27% |
| 2016 | 664.15 Million CNY | -31.98% |
| 2015 | 976.43 Million CNY | 63.27% |
| 2014 | 598.05 Million CNY | 28.68% |
| 2013 | 464.76 Million CNY | 14.5% |
| 2012 | 405.92 Million CNY | 23.82% |
| 2011 | 327.83 Million CNY | 35.04% |
| 2010 | 242.75 Million CNY | 16.27% |
| 2009 | 208.78 Million CNY | 18.02% |
| 2008 | 176.9 Million CNY | 20.14% |
| 2007 | 147.24 Million CNY | 16.34% |
| 2006 | 126.56 Million CNY | 16.46% |
| 2005 | 108.67 Million CNY | 28.43% |
| 2004 | 84.61 Million CNY | 11.48% |
| 2003 | 75.9 Million CNY | 42.59% |
| 2002 | 53.23 Million CNY | -11.93% |
| 2001 | 60.44 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 1.31 Billion CNY | 0.78% |
| 2024 Q2 | 1.3 Billion CNY | 2.49% |
| 2024 Q1 | 1.27 Billion CNY | -4.5% |
| 2023 Q1 | 1.17 Billion CNY | 4.61% |
| 2023 Q2 | 1.17 Billion CNY | -0.46% |
| 2023 Q3 | 1.31 Billion CNY | 11.87% |
| 2023 Q4 | 1.33 Billion CNY | 1.45% |
| 2023 FY | 1.33 Billion CNY | 18.18% |
| 2022 Q2 | 994.8 Million CNY | 6.69% |
| 2022 Q4 | 1.12 Billion CNY | 5.76% |
| 2022 FY | 1.12 Billion CNY | 22.14% |
| 2022 Q1 | 932.38 Million CNY | 0.97% |
| 2022 Q3 | 1.06 Billion CNY | 7.2% |
| 2021 Q3 | 986.96 Million CNY | 5.94% |
| 2021 Q2 | 931.59 Million CNY | -1.75% |
| 2021 Q1 | 948.15 Million CNY | -1.38% |
| 2021 FY | 923.41 Million CNY | -3.96% |
| 2021 Q4 | 923.41 Million CNY | -6.44% |
| 2020 Q4 | 961.45 Million CNY | -21.03% |
| 2020 Q1 | 1.21 Billion CNY | -4.67% |
| 2020 Q3 | 1.21 Billion CNY | -2.98% |
| 2020 Q2 | 1.25 Billion CNY | 3.35% |
| 2020 FY | 961.45 Million CNY | -24.51% |
| 2019 Q4 | 1.27 Billion CNY | 3.17% |
| 2019 Q2 | 1.28 Billion CNY | 4.37% |
| 2019 Q1 | 1.23 Billion CNY | 5.77% |
| 2019 FY | 1.27 Billion CNY | 9.51% |
| 2019 Q3 | 1.23 Billion CNY | -3.85% |
| 2018 Q3 | 1 Billion CNY | 1.59% |
| 2018 Q4 | 1.16 Billion CNY | 16.02% |
| 2018 Q2 | 986.78 Million CNY | 13.49% |
| 2018 Q1 | 869.51 Million CNY | -4.62% |
| 2018 FY | 1.16 Billion CNY | 27.58% |
| 2017 Q1 | 696.29 Million CNY | 4.84% |
| 2017 FY | 911.66 Million CNY | 37.27% |
| 2017 Q2 | 787.8 Million CNY | 13.14% |
| 2017 Q3 | 812.35 Million CNY | 3.12% |
| 2017 Q4 | 911.66 Million CNY | 12.23% |
| 2016 FY | 664.15 Million CNY | -31.98% |
| 2016 Q2 | 940.21 Million CNY | -3.1% |
| 2016 Q1 | 970.32 Million CNY | -0.63% |
| 2016 Q3 | 911.42 Million CNY | -3.06% |
| 2016 Q4 | 664.15 Million CNY | -27.13% |
| 2015 Q2 | 843.49 Million CNY | 39.52% |
| 2015 Q4 | 976.43 Million CNY | 10.56% |
| 2015 Q3 | 883.13 Million CNY | 4.7% |
| 2015 FY | 976.43 Million CNY | 63.27% |
| 2015 Q1 | 604.57 Million CNY | 1.09% |
| 2014 FY | 598.05 Million CNY | 28.68% |
| 2014 Q1 | 427.2 Million CNY | -8.08% |
| 2014 Q2 | 479.84 Million CNY | 12.32% |
| 2014 Q3 | 552.47 Million CNY | 15.14% |
| 2014 Q4 | 598.05 Million CNY | 8.25% |
| 2013 Q4 | 464.76 Million CNY | 13.56% |
| 2013 FY | 464.76 Million CNY | 14.5% |
| 2013 Q3 | 409.27 Million CNY | 3.84% |
| 2013 Q2 | 394.15 Million CNY | 7.13% |
| 2013 Q1 | 367.92 Million CNY | -9.36% |
| 2012 Q4 | 405.92 Million CNY | 23.0% |
| 2012 Q3 | 330.02 Million CNY | 0.65% |
| 2012 Q2 | 327.88 Million CNY | 1.64% |
| 2012 FY | 405.92 Million CNY | 23.82% |
| 2012 Q1 | 322.58 Million CNY | -1.6% |
| 2011 Q4 | 327.83 Million CNY | 15.36% |
| 2011 Q1 | 241.47 Million CNY | -0.53% |
| 2011 Q2 | 238.07 Million CNY | -1.41% |
| 2011 Q3 | 284.16 Million CNY | 19.36% |
| 2011 FY | 327.83 Million CNY | 35.04% |
| 2010 Q2 | 218.04 Million CNY | 1.56% |
| 2010 FY | 242.75 Million CNY | 16.27% |
| 2010 Q3 | 216.16 Million CNY | -0.86% |
| 2010 Q1 | 214.7 Million CNY | 2.83% |
| 2010 Q4 | 242.75 Million CNY | 12.3% |
| 2009 Q1 | 148.35 Million CNY | -16.14% |
| 2009 FY | 208.78 Million CNY | 18.02% |
| 2009 Q4 | 208.78 Million CNY | 0.83% |
| 2009 Q3 | 207.07 Million CNY | 42.37% |
| 2009 Q2 | 145.44 Million CNY | -1.96% |
| 2008 Q4 | 176.9 Million CNY | 5.29% |
| 2008 FY | 176.9 Million CNY | 20.14% |
| 2008 Q3 | 168.01 Million CNY | 13.99% |
| 2008 Q2 | 147.39 Million CNY | 3.28% |
| 2008 Q1 | 142.71 Million CNY | -3.08% |
| 2007 Q2 | 121.26 Million CNY | 0.23% |
| 2007 Q3 | 173.23 Million CNY | 42.86% |
| 2007 FY | 147.24 Million CNY | 16.34% |
| 2007 Q4 | 147.24 Million CNY | -15.0% |
| 2007 Q1 | 120.98 Million CNY | -4.41% |
| 2006 Q1 | 109.48 Million CNY | 0.74% |
| 2006 Q3 | 111.65 Million CNY | 1.98% |
| 2006 Q4 | 126.56 Million CNY | 13.35% |
| 2006 FY | 126.56 Million CNY | 16.46% |
| 2006 Q2 | 109.48 Million CNY | 0.0% |
| 2005 FY | 108.67 Million CNY | 28.43% |
| 2005 Q4 | 108.67 Million CNY | 20.95% |
| 2005 Q3 | 89.84 Million CNY | -0.04% |
| 2005 Q1 | 97.11 Million CNY | 14.78% |
| 2005 Q2 | 89.88 Million CNY | -7.45% |
| 2004 Q2 | 83.19 Million CNY | 9.94% |
| 2004 Q1 | 75.67 Million CNY | -0.3% |
| 2004 FY | 84.61 Million CNY | 11.48% |
| 2004 Q4 | 84.61 Million CNY | -1.13% |
| 2004 Q3 | 85.58 Million CNY | 2.86% |
| 2003 Q4 | 75.9 Million CNY | 0.0% |
| 2003 FY | 75.9 Million CNY | 42.59% |
| 2002 FY | 53.23 Million CNY | -11.93% |
| 2001 FY | 60.44 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 2.31 Billion CNY | 42.396% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.37 Billion CNY | 60.547% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 242.85 Million CNY | -448.865% |
| Aurora Optoelectronics Co.,Ltd. | 70.61 Million CNY | -1787.54% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 42.94 Million CNY | -3003.798% |
| NanJing Pharmaceutical Company Limited | 5.79 Billion CNY | 77.01% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 569.53 Million CNY | -134.047% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 705.34 Million CNY | -88.981% |